Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma

BACKGROUND: Survival outcomes for patients with osteosarcoma (OS) have remained stagnant over the past three decades. Insulin-like growth factor 1 receptor (IGF1R) is over-expressed in a number of malignancies, and anti-IGF1R antibodies have and are currently being studied in clinical trials. Unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yu, Roth, Michael, Piperdi, Sajida, Montoya, Kristofer, Sowers, Rebecca, Rao, Pulivarthi, Geller, David, Houghton, Peter, Kolb, E. Anders, Gill, Jonathan, Gorlick, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149550/
https://www.ncbi.nlm.nih.gov/pubmed/25170759
http://dx.doi.org/10.1371/journal.pone.0106249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149550/
https://www.ncbi.nlm.nih.gov/pubmed/25170759
http://dx.doi.org/10.1371/journal.pone.0106249

Ejemplares similares